Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery

NCT00408564 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

BIOLOGICAL: cetuximab
DRUG: capecitabine
DRUG: oxaliplatin
PROCEDURE: conventional surgery
RADIATION: radiation therapy
DRUG: Gemcitabine

Sponsor

Medical University of South Carolina